Form 4: CareDx Director Peter Maag Receives 12,103 Restricted Stock Units

CareDx, Inc. Director Peter Maag was granted 12,103 shares of common stock in the form of Restricted Stock Units (RSUs) on June 13, 2025, as part of his compensation.

Summary

• Peter Maag, a Director at CareDx, Inc. (CDNA), was granted 12,103 shares of common stock on June 13, 2025.
• These shares are in the form of Restricted Stock Units (RSUs), which were acquired at a price of $0 per share.
• The RSUs are scheduled to vest in a single installment on the earlier of June 13, 2026, or the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.
• Following this transaction, Mr. Maag's beneficial ownership of CareDx, Inc. common stock totals 328,846 shares.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates alignment of a director's interests with shareholders through equity compensation, which is a standard and generally well-regarded practice.

Positives

• The grant of Restricted Stock Units (RSUs) to Director Peter Maag aligns his interests with those of shareholders, incentivizing long-term performance and commitment to the company's success.

Negatives

• No negative information is presented in this routine insider transaction filing.

Risks

• This Form 4 filing does not disclose specific risks.

Future Outlook

The 12,103 Restricted Stock Units granted to Director Peter Maag are scheduled to vest on the earlier of June 13, 2026, or the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Industry Context

This filing is a standard disclosure of an insider equity transaction, common across all industries for publicly traded companies, reflecting routine compensation practices for board members.

Related Party Transactions

• The grant of 12,103 Restricted Stock Units to Director Peter Maag constitutes a related party transaction, which is a standard form of equity compensation for board members and is disclosed as per SEC regulations.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's interests with long-term shareholder value creation, though it represents a minor potential for future dilution upon vesting.

Next Steps

• The vesting of the 12,103 Restricted Stock Units will occur on the earlier of June 13, 2026, or the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Key Dates

Keywords

CareDx, CDNA, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Peter Maag, Director Compensation, Equity Grant